Stocks
IGM Biosciences (IGMS) R&D/CAPEX US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| R&D/CAPEX, % | 1 509% | 371.6% | 959.1% | 1 757% | 1 674% | 1 887% | |||
| Changes by years, y/y, % | -898pp | -1 137pp | +588pp | +798pp | -83pp | -7.0% | |||
IGM Biosciences. R&D/CAPEX, %
IGM Biosciences. R&D/CAPEX, changes, pp
IGM Biosciences (IGMS) R&D/CAPEX US GAAP (quarter values) |
||||||||
| 2023Q1 | 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | LTM ? | |||
| R&D/CAPEX, % | 1 293% | 1 423% | 1 776% | 3 592% | 1 764% | 1 887% | ||
| Changes by years, y/y, % | -13pp | -1 167pp | -1pp | +1 921pp | +471pp | |||
| Changes by quarters, q/q, % | -378pp | +130pp | +353pp | +1 816pp | -1 828pp | |||
